TY - JOUR
T1 - Plate reader-based assays for measuring cell viability, neuroprotection and calcium in primary neuronal cultures
AU - Burroughs, Stephanie L.
AU - Duncan, R. Scott
AU - Rayudu, Parvathi
AU - Kandula, Prasanthi
AU - Payne, Andrew J.
AU - Clark, Julie L.
AU - Koulen, Peter
AU - Kaja, Simon
N1 - Funding Information:
This study was supported in part by the National Headache Foundation (S.K.), and grants EY014227 from NIH/NEI , RR022570 , RR027093 from NIH/NCRR and AG010485 , AG022550 and AG027956 from NIH/NIA , the Felix and Carmen Sabates Missouri Endowed Chair in Vision Research (P.K.), and the Vision Research Foundation of Kansas City . We thank Margaret, Richard and Sara Koulen for generous support and encouragement.
PY - 2012/1/15
Y1 - 2012/1/15
N2 - Drug discovery and development efforts critically rely on cell-based assays for high-throughput screening. These assay systems mostly utilize immortalized cell lines, such as human embryonic kidney cells, and can provide information on cytotoxicity and cell viability, permeability and uptake of compounds as well as receptor pharmacology. While this approach has proven extremely useful for single-target pharmacology, there is an urgent need for neuropharmacological studies to screen novel drug candidates in a cellular environment resembles neurons in vivo more closely, in order to gain insight into the involvement of multiple signaling pathways. Primary cultured neuronal cells, such as cortical neurons, have long been used for basic research and low-throughput screening and assay development, and may thus be suitable candidates for the development of neuropharmacological high-throughput screening approaches. We here developed and optimized protocols for the use of primary cortical neuronal cells in high-throughput assays for neuropharmacology and neuroprotection, including calcium mobilization, cytotoxicity and viability as well as ion channel pharmacology. Our data show low inter-experimental variability and similar reproducibility as conventional cell line assays. We conclude that primary neuronal cultures provide a viable alternative to cell lines in high-throughput assay systems by providing a cellular environment more closely resembling physiological conditions in the central nervous system.
AB - Drug discovery and development efforts critically rely on cell-based assays for high-throughput screening. These assay systems mostly utilize immortalized cell lines, such as human embryonic kidney cells, and can provide information on cytotoxicity and cell viability, permeability and uptake of compounds as well as receptor pharmacology. While this approach has proven extremely useful for single-target pharmacology, there is an urgent need for neuropharmacological studies to screen novel drug candidates in a cellular environment resembles neurons in vivo more closely, in order to gain insight into the involvement of multiple signaling pathways. Primary cultured neuronal cells, such as cortical neurons, have long been used for basic research and low-throughput screening and assay development, and may thus be suitable candidates for the development of neuropharmacological high-throughput screening approaches. We here developed and optimized protocols for the use of primary cortical neuronal cells in high-throughput assays for neuropharmacology and neuroprotection, including calcium mobilization, cytotoxicity and viability as well as ion channel pharmacology. Our data show low inter-experimental variability and similar reproducibility as conventional cell line assays. We conclude that primary neuronal cultures provide a viable alternative to cell lines in high-throughput assay systems by providing a cellular environment more closely resembling physiological conditions in the central nervous system.
UR - http://www.scopus.com/inward/record.url?scp=81555214112&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=81555214112&partnerID=8YFLogxK
U2 - 10.1016/j.jneumeth.2011.09.007
DO - 10.1016/j.jneumeth.2011.09.007
M3 - Article
C2 - 21968036
AN - SCOPUS:81555214112
SN - 0165-0270
VL - 203
SP - 141
EP - 145
JO - Journal of Neuroscience Methods
JF - Journal of Neuroscience Methods
IS - 1
ER -